One Blood Test, Two Verdicts: FDA Advisers Weigh Galleri Wednesday After Randomized Trial Missed Its Main Goal

FDA advisers vote Sept. 23 on the Galleri multi-cancer blood test. What its randomized trial found and what a positive result means for adults 50+.

Have A Referral?